tiprankstipranks

Thorne HealthTech downgraded to Market Perform from Outperform at TD Cowen

TD Cowen downgraded Thorne HealthTech to Market Perform from Outperform with a price target of $10.20, up from $8, after L Catterton agreed to acquire all outstanding shares of common stock of Thorne for $10.20 per share in cash.

Confident Investing Starts Here:

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

See the top stocks recommended by analysts >>

Read More on THRN:

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.

Report an Issue